Glory Health Industry Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Zhangsun Zhang

İcra Kurulu Başkanı

CN¥3.0m

Toplam tazminat

CEO maaş yüzdesi	100.0%
CEO görev süresi	no data
CEO sahipliği	76.7%
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	less than a year

Son yönetim güncellemeleri

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

CEO Tazminat Analizi

Zhangsun Zhang'un ücretlendirmesi Glory Health Industry'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-CN¥356m
Mar 31 2024	n/a	n/a	-CN¥460m
Dec 31 2023	CN¥3m	CN¥3m	-CN¥564m
Sep 30 2023	n/a	n/a	-CN¥531m
Jun 30 2023	n/a	n/a	-CN¥497m
Mar 31 2023	n/a	n/a	-CN¥705m
Dec 31 2022	CN¥3m	CN¥3m	-CN¥913m
Sep 30 2022	n/a	n/a	-CN¥817m
Jun 30 2022	n/a	n/a	-CN¥721m
Mar 31 2022	n/a	n/a	-CN¥246m
Dec 31 2021	CN¥3m	CN¥3m	CN¥228m
Sep 30 2021	n/a	n/a	CN¥261m
Jun 30 2021	n/a	n/a	CN¥294m
Mar 31 2021	n/a	n/a	CN¥196m
Dec 31 2020	CN¥3m	CN¥3m	CN¥99m
Sep 30 2020	n/a	n/a	CN¥301m
Jun 30 2020	n/a	n/a	CN¥502m
Mar 31 2020	n/a	n/a	CN¥681m
Dec 31 2019	CN¥3m	CN¥3m	CN¥860m
Sep 30 2019	n/a	n/a	CN¥943m
Jun 30 2019	n/a	n/a	CN¥1b
Mar 31 2019	n/a	n/a	CN¥1b
Dec 31 2018	CN¥3m	CN¥3m	CN¥1b

Tazminat ve Piyasa: Zhangsun 'nin toplam tazminatı ($USD 411.06K ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 231.54K ).

Tazminat ve Kazançlar: Zhangsun 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Zhangsun Zhang (67 yo)

no data

Görev süresi

CN¥3,000,000

Tazminat

Mr. Zhangsun Zhang is the Founder of Glory Health Industry Limited (formerly known as Guorui Properties Limited). Mr. Zhang also serves as Chairman and President of Glory Health Industry Limited (formerly...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zhangsun Zhang	Chairman & President	no data	CN¥3.00m	76.71% HK$ 347.8m
Xueer Donghas	Chief Financial Officer	no data	Veri yok	Veri yok
Wenjuan Ruan	VP & Executive Director	no data	CN¥2.27m	Veri yok
Zhenhe Hao	VP & Executive Director	3.1yrs	CN¥240.00k	Veri yok
Bin Li	Executive President	no data	Veri yok	Veri yok
Yuhong Zhao	GM of the Operation & HR Mgmt Center	no data	Veri yok	Veri yok
Zhang Chengjuan	Vice Director of the Legal Compliance Department	no data	Veri yok	Veri yok
Jingying Huang	Director of the Marketing Center	no data	Veri yok	Veri yok
Huadong Li	Chief Human Resources Officer	no data	Veri yok	Veri yok
Huabin Yang	Executive Director	less than a year	Veri yok	Veri yok
Yang Feng	Executive Director	less than a year	Veri yok	Veri yok
Lok Tung Chan	Company Secretary & Process Agent	less than a year	Veri yok	Veri yok

0.9yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: 2329 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.9 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zhangsun Zhang	Chairman & President	no data	CN¥3.00m	76.71% HK$ 347.8m
Wenjuan Ruan	VP & Executive Director	no data	CN¥2.27m	Veri yok
Zhenhe Hao	VP & Executive Director	3.1yrs	CN¥240.00k	Veri yok
Yuhong Zhao	GM of the Operation & HR Mgmt Center	less than a year	Veri yok	Veri yok
Huabin Yang	Executive Director	less than a year	Veri yok	Veri yok
Yang Feng	Executive Director	less than a year	Veri yok	Veri yok
Jinrong Chen	Independent Non-Executive Director	less than a year	Veri yok	Veri yok
Zhidong Deng	Independent Non-Executive Director	less than a year	Veri yok	Veri yok
Hao Yuan	Independent Non-Executive Director	less than a year	Veri yok	Veri yok

0.9yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 2329 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 0.9 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/12/31 01:44
Gün Sonu Hisse Fiyatı	2024/12/31 00:00
Kazançlar	2024/06/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Glory Health Industry Limited 0 Bu analistlerden 0, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum

Glory Health Industry Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Glory Health Industry Limited Announces Change of Company Secretary

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Recent updates

Glory Health Industry Limited Announces Change of Company Secretary

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş

Şirket Analizi ve Finansal Veri Durumu

Veri Kaynakları

Analiz Modeli ve Kar Tanesi